Molecular profiling applications in clinical oncology are evolving faster than ever relying on advances in technology and allowing clinicians to identify the molecular and genetic signatures that help deliver treatments that are highly specific to a given tumor type....
"Newborn screening is a public health initiative. The goal is to look for disease where early identification makes a difference in the outcome as compared to identifying it symptomatically later in life."-Â Dr. Jerry Vockley...
Centered on revolutionary science, the story of mRNA technology as a new class of drug is packed with passion and brilliance....
I wanted to share a quote from Dr. Julie Johnson, PharmD, Dean and Distinguished Professor of Pharmacy, College of Pharmacy, University of Florida and honoree at PMWC 2021 Pittsburgh...
We are excited to host the 20th Precision Medicine World Conference (PMWC) in Pittsburgh on September 23-24, 2021....
Data is the most important asset when it comes to making informed treatment decisions, to accelerate or optimize therapeutic development, and to reduce cost in the healthcare system by administering therapeutics in a targeted and optimized way....
Biology and Technology are Transforming the Future of Drug Discovery. ...
It’s Time to Realize the Full Potential of Precision Medicine. Our industry has learned a lot from addressing the challenges of COVID-19 diagnostics, treatment and vaccine development....
We are pleased to share with you the agenda for the second virtual PMWC 2021 conference on June 14-18, with the timely program theme: Precision Medicine in the Era of a Pandemic Recovery....
Q: The U.S. is investing heavily in tracking the coronavirus via large-scale sequencing efforts. While the country has an enormous sequencing capacity, funding and coordination roadblocks for surveillance seem to hold back progress. What are major challenges we need to overcome to address this issue? A:...
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish